BY AGE 7, TERESA CODY’S SON, NEAL, had yet to say his first word. He has Down syndrome, a disorder caused by an extra copy of chromosome 21, found in 6,000 babies every year in the U.S. There’s no cure, and most people with the diagnosis have an IQ about 50 points below average and a shorter life expectancy.
Desperate to improve her son’s cognition, Cody gave him supplements, vitamins, and medication, which led her to an unlikely treatment: Prozac. She found studies that claim the antidepressant—also known as fluoxetine— could stimulate the growth of new neurons in mice. She convinced Neal’s pediatrician it couldn’t hurt, so he added the drug to Neal’s supplement regimen. Cody believes the drug sped Neal’s development, and although there’s no way to prove causation,…